natgillin/translations-raw huggingface dataset:
hypersensitivitet,
hypersensitivity,
hypersensitivitets reaktion, herunder udslæt
hypersensitivity reaction including rash
Hypersensitivitetsreaktioner inklusive sjældne tilfælde af bronkokonstriktion, urticaria og angioødem og meget sjældne tilfælde af anafylaktisk reaktion/shock
Hypersensitivity reactions including rare cases of bronchoconstriction, urticaria and angioedema, and very rare cases of anaphylactic reaction/shock
Hypersensitivitetsreaktioner inklusive sjældne tilfælde af bronkospasme, urticaria og angioødem og meget sjældne tilfælde af anafylaktisk reaktion/shock
Hypersensitivity reactions including rare cases of bronchospasm, urticaria and angioedema, and very rare cases of anaphylactic reaction/shock
Hypertension
Hyper-tension
Hypertension
Hypertension b
Hypertension
Hypertension d
Hypertension
Hypertension Vasospasm Flushing
Hypertension
Uncommon
hypertension (3,2 % over for 2,5 %)
hypertension (3.2% vs 2.5%)
Hypertension (forhøjet blodtryk)
Hypertension (increase in blood pressure)
Hypertension (forhøjet blodtryk, procedural hypertension, forhøjet diastolisk blodtryk), rødmen (herunder hedeture, hyperæmi, nattesved), hypotension (herunder nedsat blodtryk)
Hypertension (increased blood pressure, procedural hypertension, increased diastolic blood pressure), flushing (including hot flush, hyperaemia, night sweats), hypotension (including decreased blood pressure)
Hypertension (forværret), ortostatisk hypotension
Hypertension (aggravated), orthostatic hypotension
Hypertension (forværret), ortostatisk hypotension
Respiratory, thoracic and mediastinal disorders
Hypertension (Gilenya kan forårsage en let forhøjelse af blodtrykket)
Hypertension (Gilenya may cause a mild increase in blood pressure)
Hypertension (inkl. forværret)
Hypertension(incl. aggravated)
Hypertension (inklusive hypertensiv krise), hypotension, ortostatisk hypotension, flushing, kolde ekstremiteter
Hypertension (including hypertensis crisis), hypotension, orthostatic hypotension, flushing, peripheral coldness
Hypertension (se pkt.
Anxiety
Hypertension (øgning i blodtryk)
Hypertension (increase in blood pressure)
Hypertension Bleghed
Hypertension Pallor
Hypertension blev rapporteret hos 26,5% af de patienter, som fik sunitinib i fase 3 pNET-studiet, og hos 4,9% af de patienter, der fik placebo.
Hypertension was reported in 26.5% of patients receiving sunitinib in a Phase 3 pNET study, compared to 4.9% of patients receiving placebo.
hypertension er derfor
benzodiazepine.
hypertension er kontraindiceret.
contraindicated.
Hypertension Hedetur Angiopati1
Hypertension Hot flush Angiopathy1
Hypertension Hypertensiv krise
Hypertension Hypertensive crisis
Hypertension Hypotension Hæmatoma* Hedestigning*
Hypertension Hypotension
HYPERTENSION i denne tabel for
HYPERTENSION in this table for
Hypertension kan øge risikoen for arterietrombose.
Hypertension may contribute to risk of arterial thrombotic events.
Hypertension var en meget almindelig bivirkning, i kliniske studier.
Hypertension was a very common adverse reaction reported in clinical trials.
Hypertension Venetrombose/ tromboembolisme (blodpropper)
Hypertension Venous thrombosis/thromboembolism
hypertension)
and hypertension)
Hypertension*, hypotension*, ortostatisk hypotension
Urinary tract infection
Hypertension,
Pulmonary
Hypertension, bleghed, kolde perifere legemsdele
Hypertension, pallor, peripheral coldness
Hypertension, bleghedb
Hypertension, pallorb
Hypertension, blødning*
Hypertension, Haemorrhage
Hypertension, der er svær at regulere.
Uncontrolled hypertension.
Hypertension, flushing, hedeture
Hypertension, flushing, hot flush
hypertension, forværret hypertension
Hypertension, hypertension aggravated
Hypertension, hypotension
Hypertension (aggravated), orthostatic hypotension
Hypertension, hypotension Hedeture
Hypertension, hypotension Flushes
Hypertension, hypotension, rødme
hypertension, hypotension, flushing
Hypertension, hæmatom, subduralt hæmatom, kuldefornemmelser i ekstremiteter, hypotension, Raynaud’s syndrom
Hypertension, haematoma, subdural haematoma, peripheral coldness, hypotension, Raynaud’s phenomenon
Hypertension, lymfeødem
Hypertension, lymphoedema
Hypertension, lymfocele
Dermatitis exfoliative
Hypertension, lymfødem
Hypertension, lymphoedema
hypertension, orthostatisk hypotension, hypotension
respiratory failure4
hypertension, orthostatisk hypotension, hypotension
respiratory failure4,
hypertension, PREZISTA og
hypertension with PREZISTA and
hypertension, rødme, hæmatom
aortic aneurysm,
hypertension, rødmen
hypertension, flushing
Hypertension, rødmen, hæmatom
hypertension, flushing, haematoma
Hypertension, som ikke er tilstrækkeligt kontrolleret med antihypertensiv behandling, eller ved forekomst af hypertensiv krise eller hypertensiv encefalopati
Hypertension that is not adequately controlled with anti-hypertensive therapy or occurrence of hypertensive crisis or hypertensive encephalopathy
Hypertension, vasovagal reaktion (inkl. hypotension)
Hypertension, vasovagal reaction (incl. hypotension)
hypertension.
arterial hypertension.
hypertension: Samtidig
When co-administered with
Hypertensiv krise
hypertensive crisis
Hypertensiv krise*
Hypertensive crisis
Hypertensiv krise3 Ortostatisk hypotension2 Perifer kulde- fornemmelse
Hypertensive crisis3 Orthostatic hypotension2 Peripheral coldness
Hypertensiv krise4
Hypertensive crisis4
Hypertensive kriser med encefalopati og krampeanfald er forekommet under behandling med epoetin alfa hos patienter med tidligere normalt eller lavt blodtryk; dette kræver øjeblikkeligt lægetilsyn og igangsættelse af intensiv behandling.
Hypertensive crisis with encephalopathy and seizures, requiring the immediate attention of a physician and intensive medical care, have occurred also during epoetin alfa treatment in patients with previously normal or low blood pressure.
Hypertensive patienter med type 2 diabetes og nyresygdom
Hypertensive patients with type 2 diabetes and renal disease
Hypertensive patienter med type 2-diabetes og nefropati
Hypertensive patients with type 2 diabetes and renal disease
Hypertermi
Common
hypertermi (3-6 timer efter injektion)
hyperthermia (3-6 hours after injection)
hyperthyreoidism, tidligere hæmoragisk apopleksi eller risikofaktorer der øger risikoen for hæmoragisk apopleksi.
hyperthyroidism, a history of haemorrhagic stroke or with risk factors which could increase the risk of haemorrhagic stroke.
Hyperthyreoidisme (overaktiv skjoldbruskkirtel)
Hyperthyroidism (overactive thyroid gland)
Hyperthyreoidisme, virilisering
Hyperthyroidism, virilism
hypertoni,
General
Hypertoniam, perifer neuropatiam
Hypertoniaam, peripheral neuropathyam
Hypertoni°
Hypertonia°
Hypertoni°
Myasthenia
Hypertri-- glyceridæmi
Hypertri- Glyceridemia
Hypertriglyceridæmi er blevet forbundet med en øget risiko for at udvikle pankreatit (bugspytkirtelbetændelse). hvis du skal opereres, eller hvis du sidder eller ligger ned i længere tid (se punkt 2 ‘Blodpropper’). hvis du lige har født, har du også en øget risiko for blodpropper.
Hypertriglyceridaemia has been associated with an increased risk of developing pancreatitis (inflammation of the pancreas); if you need an operation, or you are off your feet for a long time (see in section 2 ‘Blood clots’); if you have just given birth you are at an increased risk of blood clots.
Hypertriglyceridæmi har været forbundet med en øget risiko for at udvikle pancreatitis (betændelse i bugspytkirtlen); hvis du skal opereres, eller hvis du er sengeliggende i en længere periode (se under punkt 2 ”Blodpropper”) hvis du lige har født, har du en øget risiko for blodpropper.
Hypertriglyceridaemia has been associated with an increased risk of developing pancreatitis (inflammation of the pancreas); if you need an operation or if you are off your feet for a long time (see in section 2 ‘Blood clots). if you have just given birth you are at an increased risk of blood clots.
Hypertriglyceridæmi har været forbundet med en øget risiko for at udvikle pankreatitis (betændelse i bugspytkirtlen); hvis du skal opereres, eller hvis du er sengeliggende i en længere periode (se under punkt 2 ”Blodpropper”) hvis du lige har født, har du en øget risiko for blodpropper.
Hypertriglyceridaemia has been associated with an increased risk of developing pancreatitis (inflammation of the pancreas); if you need an operation or if you are off your feet for a long time (see in section 2 ‘Blood clots). if you have just given birth you are at an increased risk of blood clots.
Hypertriglyceridæmi*
hypertriglyceridaemia
hypertriglyceridæmi, hyperlipidæmi
hypertriglyceridaemia, hyperlipidaemia
Hypertriglyceridæmi, hypofosfatæmi, diabetes mellitus, hyperlipidæmi, hypokaliæmi, dehydrering, hypokalcæmi
Hypertriglyceridaemia, hypophosphataemia, diabetes mellitus, hyperlipidaemia, hypokalaemia, dehydration, hypocalcaemia
hypertriglyceridæmi, hypokalcæmi, hyponatriæmi
Hypertriglyceridaemia, hypocalcaemia, hyponatraemia
hypertriglyceridæmi1, 2, hyperglykæmi1, nedsat appetit2
hypertriglyceridaemia1, 2, hyperglycaemia1, decreased appetite2
Hypertriglyceridæmi3
hypertriglyceridaemia3
Hypertriglyceridæmib Gradc 1
Hypertriglyceridaemiab CTCAEc grade 1
Hypertriglyceridæmi§, hyperurikæmi, øget appetit
Hypertriglyceridemia§, hyperuricemia, increased appetite
Hypertrofi af endometrieta (endometriets tykkelse påvist med ultralyd)
Endometrial hypertrophya (sonographic endometrial thickness)
Hypertrofi i lymfevæv (f.eks. tonsiller) forbundet med komplikationer, såsom snorken, søvnapnø og kronisk mellemøreeffusion, er rapporteret ved anvendelse af INCRELEX.
Lymphoid tissue (e.g., tonsillar) hypertrophy associated with complications, such as snoring, sleep apnoea, and chronic middle-ear effusions have been reported with the use of INCRELEX.
hypertrofisk forbenet callus i forbindelse med vedvarende (>10 uger) moderat bløddelshævelse og overdreven slikken af incisionsområdet
Exuberant bony callus associated with persistent (>10 weeks) moderate soft tissue swelling and excessive licking of the incision area.
hypertrofisk forbenet callus i forbindelse med vedvarende (>10 uger) moderat bløddelshævelse og overdreven slikken af incisionsområdet.
Exuberant bony callus associated with persistent (>10 weeks) moderate soft tissue swelling and excessive licking of the incision area.
hypertyreoidisme, tyroiditis
hyperthyroidism, thyroiditis
hypertyreose
hyperthyroidis m
hypertyreose
hyperthyroidism
Hypertyreosec
Hyperthyroidismc
Hypertyroidisme
Hyperthyroidism
Hypertyroidisme forekom hos 96 (3,4%) patienter, som fik pembrolizumab, inklusive tilfælde af grad 2 eller 3 hos henholdsvis 22 (0,8%) og 4 (0,1%) patienter.
Hyperthyroidism occurred in 96 (3.4%) patients, including Grade 2 or 3 cases in 22 (0.8%) and 4 (0.1%) patients, respectively, receiving pembrolizumab.
Hypertyroidisme gik over hos 71 (74%) patienter.
Hyperthyroidism resolved in 71 (74%) patients.
hypertyroidisme, hypotyroidismeb
hyperthyroidism, hypothyroidismb
Hypertyroidisme, thyroideaforstyrrelser
Hyperthyroidism, Thyroid disorders
Hyperurikæmi
disorders
Hyperurikæmi (forhøjet urinsyre i blodet)
Blood alkaline phosphatase increased
Hyperurikæmi (forhøjet urinsyre i blodet)
Hyperuricaemia (blood uric acid increased)
Hyperurikæmi a
Hyperuricaemiaa
Hyperurikæmi Reduceret blodglucose Forhøjet laktat- dehydrogenas e i blodet
Hyperuricaemia Blood glucose decreased Blood lactate dehydrogenase increased
Hyperurikæmi, hyperammonæmi
Hyperuricaemia, hyperammonaemia
Hyperurikæmi, hypokalcæmi, hyponatriæmi
Hyperuricaemia, hypocalcaemia, hyponatraemia,
hyperurikæmi, podagra, nedsat
Ataxia, Balance impaired
hyperurikæmib, hypokaliæmib
hyperuricaemiab, hypokalaemiab
Hyperurikæmid
Hyperuricaemiad
Hyperventilation Respirationssvigt Alveolær hæmoragi Astma
Hyperventilation Respiratory failure
Hyperventilation Respirationssvigt Alveolær hæmoragi Astma
Hyperventilation Respiratory failure Alveolar haemorrhages Asthma Atelectasis
hyperventilation, aspirations- pneumoni, rallen,
hyperventilation, pneumonia aspiration, rales, dysphonia
hyperventilering, lave iltniveauer i dit blod, sinusitis
hyperventilating, low oxygen levels in your blood, sinusitis
hyperæmi
increased
hyperæmi
Uncommon
Hyperæmi af trommehinde
Tympanic membrane hyperaemia
Hyperæmi i øje Fotofobi
Ocular hyperaemia Photophobia
Hyperæmie, hypotension
Hyperaemiae, hypotension
hyperæstesi (unormalt forøget følsomhed over for stimulering af sanserne)
hyperaesthesia (abnormal increase in sensitivity to stimuli of the senses)
Hyperæstesi på applikationsstedet
Application site hyperaesthesia
hyperæstesi,
Hypothermia
Hyperæstesi, tremor
hyperaesthesia, tremor
Hypnotika (f.eks. diazepam, midazolam, zolpidem)
Hypnotics (e.g. diazepam, midazolam, zolpidem)
Hypo- kalcæmi**
Cholelithiasis
Hypo- kalcæmi**
Hypocalcae mia
Hypo- kalcæmi**
Hypocalcaemia
Hypo- tyreoidisme
Hypo-thyroidism
Hypo- tyreoidisme
Hypothyroidism
Hypo- tyroidisme
Hypothyroidism
Hypo-glykæmi
Hypo- glycaemia
hypoakusis
hypoacusis
Hypoalbuminæmi
Hypoalbuminaemia
Hypoalbuminæmi (albumin)
Hypoalbuminemia (albumin)
Hypoalbuminæmi, hypokaliæmi
Hypoalbuminaemia, hypokalaemia
Hypoalbuminæmif
Hypoalbuminemiaf
hypocalcæmi
hypocalcaemia
hypocalcæmi
vasodilatation,
Hypocalcæmi‡ Hypokaliæmi Vægtreduktion Nedsat appetit
Hypocalcaemia‡ Hypokalaemia Weight decreased Decreased appetite
hypofosfatasi
hypophosphatasia
Hypofosfatasi skyldes defekter i det gen, der er ansvarligt for produktionen af "ikke-vævsspecifik alkalisk fosfatase" (ALP), et enzym, der spiller en vigtig rolle i at skabe og opretholde raske knogler og regulere calcium og fosfat i kroppen.
Hypophosphatasia is caused by defects in the gene responsible for producing ‘tissue non-specific alkaline phosphatase’ (ALP), an enzyme that plays a key role in creating and maintaining healthy bones, and managing calcium and phosphate in the body.
Hypofosfatæm i
Skin and
Hypofosfatæmi
Hypophosphatae mia
Hypofosfatæmi er almindeligt forekommende i den integrerede sikkerhedspopulation i kliniske studier med dabrafenib som monoterapi (7 %) og i kombination med trametinib i fase III-studierne (3-4 %).
Hypophosphataemia has been reported commonly in the integrated safety population in clinical trials with dabrafenib monotherapy (7%) and in combination with trametinib in Phase III trials (3 to 4%).
hypofosfatæmi,
hypophosphataemia,
hypofosfatæmi, hypokaliæmi, dyslipidæmi, hyperkaliæmi, hyperglycæmi, hypocalcæmi
hypophosphataemia, hypokalaemia, dyslipidaemia, hyperkalaemia, hyperglycaemia, hypocalcaemia
hypofosfatæmi, hyponatriæmi,
Hypomagnesaemia, Hyperuricaemia, Dehydration
Hypofosfatæmi2
hypophosphataemia2
Hypofosfatæmic
Hypophosphataemiac
hypofysitis (hypopituitarisme)
hypophysitis (hypopituitarism)
Hypofysitis forekom hos 17 (0,6%) patienter, som fik pembrolizumab, inklusive tilfælde af grad 2, 3 eller 4 hos henholdsvis 6 (0,2%), 8 (0,3%) og 1 (< 0,1%) patienter.
Hypophysitis occurred in 17 (0.6%) patients, including Grade 2, 3 or 4 cases in 6 (0.2%), 8 (0.3%) and 1 (<0.1%) patients, respectively, receiving pembrolizumab.
Hypofysitis gik over hos 7 patienter, 2 med sequelae.
Hypophysitis resolved in 7 patients, 2 with sequelae.
Hypofysitis medførte seponering af pembrolizumab hos 4 (0,1%) patienter.
Hypophysitis led to discontinuation of pembrolizumab in 4 (0.1%) patients.
hypofysitisc, binyrebarkinsufficiens, tyroiditis
hypophysitisc, adrenal insufficiency, thyroiditis
Hypogammaglobulinæmi (en tilstand med lave niveauer af immunglobulin i blodet) hos patienter efter knoglemarvstransplantation med stamceller fra en anden person.
Hypogammaglobulinaemia (a condition implying low immunoglobulin levels in your blood) in patients after a stem cell transplantation (allogeneic haematopoietic stem cell transplantation), when you are given stem cells from another person.
Hypogammaglobulinæmi (en tilstand med lave niveauer af immunglobulin i blodet) og tilbagevendende bakterieinfektioner hos patienter med kronisk lymfatisk leukæmi (blodkræft, hvor der produceres for mange hvide blodceller), hvor profylaktiske antibiotika har svigtet.
Hypogammaglobulinaemia (a condition implying low immunoglobulin levels in your blood) and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (cancer of the blood where too many white blood cells are produced), in whom prophylactic antibiotics have failed.
Hypogammaglobulinæmi (en tilstand med lave niveauer af immunglobulin i blodet) og tilbagevendende bakterieinfektioner hos patienter med myelomatose (tumor bestående af celler fra knoglemarven), som ikke har reageret på vaccination mod pneumokokker.
Hypogammaglobulinaemia (a condition implying low immunoglobulin levels in your blood) and recurrent bacterial infections in myeloma (tumour composed of cells derived from the bone marrow) patients who failed to respond to pneumococcal immunisation.
hypogammaglobulinæmi (IgG < 400 mg/dl) eller IgA-mangel (IgA < 10 mg/dl)
hypogammaglobulinaemia (IgG <400 mg/dl) or IgA deficiency (IgA <10 mg/dl)
hypogammaglobulinæmi (lavt niveau af antistoffer) hos patienter:
Hypogammaglobulinaemia (low levels of antibodies) in patients:
Hypogammaglobulinæmi er rapporteret hos patienter, der har fået Cellcept i kombination med andre immunsuppressiva (hyppighed ukendt).
Hypogammaglobulinaemia has been reported in patients receiving CellCept in combination with other immunosuppressants (frequency not known).
Hypogammaglobulinæmi hos patienter efter allogen hæmatopoietisk stamcelletransplantation (HSCT).
Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).
Hypogammaglobulinæmi hos patienter efter allogen hæmopoietisk stamcelletransplantation
Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation
Hypogammaglobulinæmi hos patienter efter allogen hæmopoietisk stamcelletransplantation (HSCT).
Hypogammaglobulinaemia in patients after allogenic haematopoietic stem cell transplantation (HSCT).
Hypogammaglobulinæmi hos patienter efter allogen hæmopoietisk stamcelletransplantation Anbefalet dosis er 0,2-0,4 g/kg legemsvægt hver 3. til 4. uge.
The recommended dose is 0.2-0.4 g/kg every three to four weeks.
Hypogammaglobulinæmi hos patienter før eller efter allogen hæmatopoietisk stamcelletransplantation.
Hypogammaglobulinaemia in patients pre- and post-allogeneic hematopoietic stem cell transplantation (HSCT).
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med kronisk lymfatisk leukæmi, hvor forebyggende antibiotika ikke har virket.
Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med kronisk lymfatisk leukæmi, hvor profylaktiske antibiotika har sviget; hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med myelomatose i plateau-fasen, som ikke har reageret på pneumokokimmunisering; medfødt aids med recidiverende bakterieinfektioner
Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed; hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation; congenital AIDS with recurrent bacterial infections
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med kronisk lymfatisk leukæmi, hvor profylaktiske antibiotika har sviget; hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med myelomatose i plateau-fasen, som ikke har reageret på pneumokokimmunisering; medfødt aids med recidiverende bakterieinfektioner.
Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed; hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation; congenital AIDS with recurrent bacterial infections
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med kronisk lymfatisk leukæmi, hvor profylaktiske antibiotika har svigtet.
Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med kronisk lymfatisk leukæmi, hvor profylaktiske antibiotika har været uden effekt.
Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med kronisk lymfatisk leukæmi, hvor profylaktiske antibiotika har været uden effekt; hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med myelomatose i plateaufasen, som ikke har reageret på pneumokokimmunisering; medfødt aids og recidiverende bakterieinfektioner
Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed; hypogammaglobulinaemia and recurrent bacterial infections in plateau phase; multiple myeloma patients who have failed to respond to pneumococcal immunisation; congenital AIDS with recurrent bacterial infections
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med kronisk lymfatisk leukæmi, hvor profylaktiske antibiotika ikke har virket eller er kontraindiceret.
Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (CLL), in whom prophylactic antibiotics have failed or are contra-indicated.
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med myelomatose i plateaufasen, som ikke har reageret på immunisering mod pneumokokker.
Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med myelomatose i plateaufasen, som ikke har reageret på pneumokokimmunisering.
Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.
Hypogammaglobulinæmi og recidiverende bakterieinfektioner hos patienter med myelomatose.
Hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (MM) patients.
Hypogammaglobulinæmi og recidiverende infektioner hos patienter med myelomatose i plateau-fase, som ikke har reageret på pneumokokimmunisering.
Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who failed to respond to pneumococcal immunisation.
hypogammaglobulinæmi, sæsonbestemt allergi
hypogammaglobulinaemia, seasonal allergy
Hypoglycæmi8
hypoglycaemia8
HYPOGLYKÆMI (for lavt blodsukker)
HYPERGLYCAEMIA (high blood sugar levels)
Hypoglykæmi
Biotransformation
hypoglykæmi
hypo-glycaemia
Hypoglykæmi
Hypoglycemia
Hypoglykæmi
Paediatric population
Hypoglykæmi (for lavt blodsukker) kan blive meget alvorlig.
Hypoglycaemia (low blood sugar) can be very serious.
Hypoglykæmi (for lavt blodsukker), betyder, at der ikke er nok sukker i blodet.
Hypoglycaemia (low blood sugar) means that there is not enough sugar in the blood.
Hypoglykæmi (hos diabetespatienter)
Hypoglycaemia (in diabetic patients)
Hypoglykæmi (hos diabetikere)
Hypoglycaemia (in diabetic patients)
Hypoglykæmi (lavt blodsukker) er en meget almindelig bivirkning, når dulaglutid bruges sammen med lægemidler, der indeholder metformin, et sulfonylurinstof og/eller insulin.
Hypoglycaemia (low blood sugar) is very common when dulaglutide is used with medicines that contain metformin, a sulphonylurea and/or insulin.
Hypoglykæmi (lavt blodsukker) kan blive meget alvorlig.
Hypoglycaemia (low blood sugar) can be very serious.
Hypoglykæmi (lavt blodsukker).
Hypoglycaemia (low blood sugar).
Hypoglykæmi (med et sulfonylurinstof)
Hypoglycaemia (with a sulphonylurea)
Hypoglykæmi (med metformin og sulfonylurinstof)2
Hypoglycaemia (with metformin and a sulphonylurea)2
Hypoglykæmi (med sulfonylurinstof)
Hypoglycaemia (with a sulphonylurea)